VIRAX BIOLABS GROUP LTD (VRAX)

KYG9495L1251 - Common Stock

1.83  +0.08 (+4.57%)

VIRAX BIOLABS GROUP LTD

NASDAQ:VRAX (12/23/2024, 10:31:28 AM)

1.83

+0.08 (+4.57%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS SubIndustryHealth Care Distributors
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%45.81%
Sales Q2Q%-93.53%
CRS54.55
6 Month16.67%
Overview
Earnings (Last)N/A N/A
Earnings (Next)12-13 2022-12-13/bmo
Ins Owners7.07%
Inst Owners1.75%
Market Cap7.94M
Shares4.34M
PEN/A
Fwd PE44.85
Dividend YieldN/A
AnalystsN/A
Short Float %3.57%
Short Ratio0.07
IPO07-14 2022-07-14
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

VRAX Daily chart

Company Profile

Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The firm is engaged in developing a T-Cell Test technologies with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against global viral threats. Its product portfolio includes ViraxClear and Virax Immune. ViraxClear offers a range of accurate diagnostic testing kits and machines. Virax Immune is a new Covid-19 test seeking detection of T-Cell immune responses to the SARS-Cov-2 virus. Its T-Cell testing is effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Monkeypox, Hepatitis B, Malaria, Herpes and Human Papillomavirus.

Company Info

VIRAX BIOLABS GROUP LTD

Biocity Glasgow, Bo'ness Road, Newhouse

London

P: 4402077887414

Employees: 17

Website: https://www.viraxbiolabs.com

VRAX News

ChartMill News Image5 days ago - ChartmillStay updated with the stocks that are on the move in today's after-hours session.

As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

News Image6 days ago - Virax BiolabsVirax Biolabs' CEO James Foster Issues Letter to Shareholders

/PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune...

News Image13 days ago - Virax BiolabsVirax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland

/PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune...

News Image2 months ago - AB NewswireHealthcare and Biotech Stocks to Watch: MODD, CRDL, DBVT, VRAX
News Image2 months ago - Virax BiolabsVirax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland

/PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune...

News Image3 months ago - Virax BiolabsVirax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.

/PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune...

VRAX Twits

Here you can normally see the latest stock twits on VRAX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example